155 related articles for article (PubMed ID: 8636005)
21. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
22. Molecular studies into the role of CD44 variants in metastasis in gastric cancer.
Hsieh HF; Yu JC; Ho LI; Chiu SC; Harn HJ
Mol Pathol; 1999 Feb; 52(1):25-8. PubMed ID: 10439835
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
24. Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.
Chen JQ; Zhan WH; He YL; Peng JS; Wang JP; Cai SR; Ma JP
World J Gastroenterol; 2004 Mar; 10(6):776-82. PubMed ID: 15040016
[TBL] [Abstract][Full Text] [Related]
25. Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis.
Yamaguchi A; Goi T; Yu J; Hirono Y; Ishida M; Iida A; Kimura T; Takeuchi K; Katayama K; Hirose K
J Surg Oncol; 2002 Apr; 79(4):230-5. PubMed ID: 11920780
[TBL] [Abstract][Full Text] [Related]
26. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.
Li H; Guo L; Li JW; Liu N; Qi R; Liu J
Int J Oncol; 2000 Nov; 17(5):927-32. PubMed ID: 11029494
[TBL] [Abstract][Full Text] [Related]
27. Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer.
Hagiwara M; Kikuchi E; Tanaka N; Kosaka T; Mikami S; Saya H; Oya M
BMC Cancer; 2018 Jan; 18(1):113. PubMed ID: 29385995
[TBL] [Abstract][Full Text] [Related]
28. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
29. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas.
Hong RL; Lee WJ; Shun CT; Chu JS; Chen YC
Oncology; 1995; 52(4):334-9. PubMed ID: 7539903
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of combined immunohistochemical detection of CD44v and sialyl LeX expression for colorectal cancer patients undergoing curative resection.
Yamaguchi A; Goi T; Seki K; Ohtaki N; Maehara M; Kobayashi T; Niimoto S; Katayama K; Hirose K; Nakagawara G; Matsukawa S
Oncology; 1998; 55(5):400-3. PubMed ID: 9732216
[TBL] [Abstract][Full Text] [Related]
31. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers.
Tanaka K; Nishioka J; Kato K; Nakamura A; Mouri T; Miki C; Kusunoki M; Nobori T
Jpn J Cancer Res; 2001 Sep; 92(9):952-8. PubMed ID: 11572763
[TBL] [Abstract][Full Text] [Related]
32. [Expression of variant CD44 in colorectal cancer and its relationship to liver metastasis].
Yamaguchi A
Nihon Geka Gakkai Zasshi; 1998 Jul; 99(7):409-14. PubMed ID: 9742519
[TBL] [Abstract][Full Text] [Related]
33. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
[TBL] [Abstract][Full Text] [Related]
34. Distinct biological characterization of the CD44 and CD90 phenotypes of cancer stem cells in gastric cancer cell lines.
Shu X; Liu H; Pan Y; Sun L; Yu L; Sun L; Yang Z; Ran Y
Mol Cell Biochem; 2019 Sep; 459(1-2):35-47. PubMed ID: 31073886
[TBL] [Abstract][Full Text] [Related]
35. CD44 as a marker in human cancers.
Sy MS; Mori H; Liu D
Curr Opin Oncol; 1997 Jan; 9(1):108-12. PubMed ID: 9090502
[TBL] [Abstract][Full Text] [Related]
36. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
Li H; Piao L; Xu D; Xuan Y
Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
[TBL] [Abstract][Full Text] [Related]
37. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs.
Okamoto I; Morisaki T; Sasaki J; Miyake H; Matsumoto M; Suga M; Ando M; Saya H
J Natl Cancer Inst; 1998 Feb; 90(4):307-15. PubMed ID: 9486817
[TBL] [Abstract][Full Text] [Related]
38. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.
Tamura Y; Higashi M; Kitamoto S; Yokoyama S; Osako M; Horinouchi M; Shimizu T; Tabata M; Batra SK; Goto M; Yonezawa S
PLoS One; 2012; 7(11):e49251. PubMed ID: 23152882
[TBL] [Abstract][Full Text] [Related]
39. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
[TBL] [Abstract][Full Text] [Related]
40. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis.
Kunishi M; Kayada Y; Yoshiga K
Int J Oral Maxillofac Surg; 1997 Aug; 26(4):280-3. PubMed ID: 9258720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
